2014 and 2015 EPS of 0.53 yuan and 0.70 yuan sales oxygen molecular sieve, the current share price corresponding PE of 21.7 times and 16.5 times, although the molecular sieve and pharmaceutical business is progressing well, but considering the LCD business by the downstream destocking impact on the company's short-term Performance factors adversely temporarily down to "recommended" rating. Event: The company released a quarterly revenues of 197 million yuan, down 10.99%; net profit attributable to shareholders of listed companies 16.98 million yuan hollow molecular sieve, down 44.58 %%; after deduction of non-realized attributable to the parent company net profit of 16.44 million yuan of shareholders sieve, down 45.25 %%. Event: The company issued a non-public issuance plans. The company raised 1.03 billion yuan of funds for expansion projects such as molecular sieve products. Release the object to include the company's actual controller of China Energy Conservation and Environmental Protection Group, including not more than ten specific investors. Comment: The issue price of not less than 9.3 yuan. The issue of energy saving target to include China Corporation (actual controller), including not more than ten specific investors, the total number of shares not more than 110 million shares. Sales oxygen molecular sieve | molecular sieve | new new zeolite molecular sieves by Shanghai Limited. Shanghai new molecular sieve Limited (www.molsionms.com) strong, credible, in Shanghai's Songjiang District elemental industry has accumulated a large number of loyal customers. The company better work attitude and constantly improving innovative ideas will lead the new molecular sieves, and you hand in hand into the brilliant, for a better future!